HN user

yeeetz

130 karma
Posts1
Comments35
View on HN

i like the aspect of engineering that's building useful or interesting or fun things for people, and i'll always experiment with new tech that facilitates that

Yeah, Twitter is super big in Japan for mainstream teen and young adult users in the 18-25 city student/young professional demographic. Same with Instagram. Mastodon adjacent stuff like Misskey, Pawoo, and Mstdn got the reputation for being for hosting weird, niche, or pretty much illegal content, and nobody really understands the point of Fediverse.

Honestly I don't fuck with social media that much besides my private Instagram, but there's more to it than just viral marketing. It's a pretty smooth app that appeals to people like my 18-25-ish age that feels like Twitter has gotten super weird and toxic. The honeymoon effect won't last forever, but it has something that a lot of social media users are looking for.

I gotta say removing political/controversial topics isn't necessarily a bad thing. Just depends on your use case and stuff. Not every platform needs to be a free speech zone—right now it feels like a pretty chill space to share food pics and talk about inconsequential topics with friends.

Threads is pretty chill and has a couple things going for it: my Insta followers/friends are automatically imported, no ads so far, recommendation algorithm works reasonably well (although it keeps pushing up Shaq for some reason), and there are some nice posi meme-y vibes. People talking about cooking and travel and music—no weird politics or crypto scammer stuff on every comment. Hopefully it stays that way for longer.

It's the CEO/leader's job to make these decisions and to course correct when he's made a mistake. Publicly admonishing himself is, at best, a pointless display of virtue signaling. He could write 10 pages groveling for forgiveness from his employees and the public, but people would complain about that too.

I suspect the overall CEO compensation package for a company the size and structure of Lattice is trivial compared to other expenses.

Unfortunately, the past several years of clinical trials have shown the amyloid beta/tau protein prion hypothesis doesn't have legs quite yet. The field is littered with failed Alzheimer's trials. Given the cost and difficulty of clinical trials, it makes sense that researchers and public health experts would go for comparatively low hanging fruit.